AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2016
Oct 12, 2016
34931_dirs_2016-10-12_48a73bc6-9109-41b6-8396-1153faa18343.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Caladrius Biosciences, Inc. (CLBS)
CIK: 0000320017
Period of Report: 2016-10-10
Reporting Person: BROWN GREGORY B (Director)
More from LISATA THERAPEUTICS, INC.
Merger & Acquisition
2026
May 29
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3